BIT
CORT icon

BlackRock Institutional Trust’s Corcept Therapeutics CORT Stock Holding History

BlackRock Institutional Trust’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$15.6M Sell
2,147,797
-94,903
-4% -$744K ﹤0.01% 2140
2016
Q3 		$14.6M Buy
2,242,700
+8,815
+0.4% +$51.3K ﹤0.01% 2100
2016
Q2 		$12.2M Sell
2,233,885
-309,662
-12% -$1.61M ﹤0.01% 2170
2016
Q1 		$11.9M Sell
2,543,547
-4,347
-0.2% -$16.9K ﹤0.01% 2151
2015
Q4 		$12.7M Buy
2,547,894
+80,101
+3% +$361K ﹤0.01% 2176
2015
Q3 		$9.28M Sell
2,467,793
-16,851
-0.7% -$85.5K ﹤0.01% 2344
2015
Q2 		$14.9M Buy
2,484,644
+48,998
+2% +$300K ﹤0.01% 2121
2015
Q1 		$13.6M Buy
2,435,646
+43,523
+2% +$158K ﹤0.01% 2188
2014
Q4 		$7.18M Buy
2,392,123
+2,492
+0.1% +$7.6K ﹤0.01% 2552
2014
Q3 		$6.4M Buy
2,389,631
+58,889
+3% +$156K ﹤0.01% 2569
2014
Q2 		$6.53M Buy
2,330,742
+6,243
+0.3% +$18.4K ﹤0.01% 2649
2014
Q1 		$10.1M Buy
2,324,499
+174,133
+8% +$609K ﹤0.01% 2417
2013
Q4 		$6.9M Buy
2,150,366
+54,859
+3% +$111K ﹤0.01% 2637
2013
Q3 		$3.33M Buy
2,095,507
+1,263
+0.1% +$2.23K ﹤0.01% 2902
2013
Q2 		$3.62M Buy
+2,094,244
New +$3.76M ﹤0.01% 2838

Other funds holding CORT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock Institutional Trust's CORT Position: Q4 2016 in Review

BlackRock Institutional Trust reduced its Corcept Therapeutics (CORT) stake by 4.2% in Q4 2016, selling an estimated $744K and leaving 2,147,797 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2140.

BlackRock Institutional Trust first reported a position in CORT in Q2 2013 and has held it in 15 quarters since. 135 funds tracked by Wall St. Rank hold CORT as of Q4 2016.

  • BlackRock Institutional Trust held 2,147,797 shares of Corcept Therapeutics worth $15.6M as of Q4 2016.
  • BlackRock Institutional Trust sold 94,903 Corcept Therapeutics shares in Q4 2016, an estimated $744K.
  • Corcept Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2140 holding.
  • BlackRock Institutional Trust first reported a position in Corcept Therapeutics in Q2 2013 and has held it in 15 quarters since.
  • 135 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.